The Enterprise Value as of December 2025 (TTM) for Chemomab Therapeutics Ltd. (CMMB) is 8.23M

According to Chemomab Therapeutics Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 8.23M. This represents a change of -56.64% compared to the average of 18.98M of the last 4 quarters.

Chemomab Therapeutics Ltd. (CMMB) Historical Enterprise Value (quarterly & annually)

How has CMMB Enterprise Value performed in the past?

The mean historical Enterprise Value of Chemomab Therapeutics Ltd. over the last ten years is 35.36M. The current 8.23M Enterprise Value has changed 2.23% with respect to the historical average. Over the past ten years (40 quarters), CMMB's Enterprise Value was at its highest in in the March 2021 quarter at 167.23M. The Enterprise Value was at its lowest in in the December 2012 quarter at -5724000.00.

Chemomab Therapeutics Ltd. (CMMB) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Chemomab Therapeutics Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Chemomab Therapeutics Ltd. (CMMB) Average Enterprise Value

How has CMMB Enterprise Value performed in the past?

The current Enterprise Value of Chemomab Therapeutics Ltd. (CMMB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Chemomab Therapeutics Ltd. (CMMB) Enterprise Value vs. Peers

How is CMMB’s Enterprise Value compared to its peers?

Chemomab Therapeutics Ltd.’s Enterprise Value is less than Kazia Therapeutics Limited (29.70M), less than Ocean Biomedical, Inc. (10.86M), greater than Theriva Biologics, Inc. (-2716502.00), greater than PMGC Holdings Inc. (-1178944.00), less than Can-Fite BioPharma Ltd. (9.50M), greater than BioVie Inc. (-12510670.00), greater than XORTX Therapeutics Inc. (1.45M), greater than InMed Pharmaceuticals Inc. (-7952583.00), greater than CERo Therapeutics Holdings, Inc. (-954844.00), greater than Galmed Pharmaceuticals Ltd. (1.23M),

Build a custom stock screener for Chemomab Therapeutics Ltd. (CMMB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Chemomab Therapeutics Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Chemomab Therapeutics Ltd. (CMMB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Chemomab Therapeutics Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.